In8bio Inc (INAB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $8.86M
Last updated: Nov 17, 2026 at 11:04 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 25.5% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 34.7, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about INAB
News
INAB Valuation
INAB Profitability: Margins, ROIC and FCF
In8bio (INAB) has an operating margin of 0.0% and a net margin of 0.0%.
- Operating margin
- 0.0%
- Net margin
- 0.0%
- ROE
- -141.8%
In8bio Competitors
The companies most similar to In8bio (INAB) include GT Biopharma, Intensity Therapeutics, Inc. Common stock and Exicure.
Sector: Healthcare
Companies most similar to In8bioINAB Analyst Ratings
In8bio (INAB) has a Buy consensus from 3 analysts: 3 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.
- Consensus
- Buy
- Analysts
- 3
- Strong Buy
- 1
- Buy
- 2
- Hold
- 0
- Sell
- 0
- Strong Sell
- 0
INAB Bull Case vs Bear Case
Bull case
- INAB beat EPS estimates in 75.0% of its last 8 reported quarters.
INAB Earnings: Beat Rate and Next Report
In8bio (INAB) beat the EPS estimate in 6 of the last 8 quarters (75.0%). Its next report is expected on Mar 10, 2027.
- Beat rate
- 6 of 8 quarters (75.0%)
- Average surprise
- 26.8%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$0.36
INAB Earnings Date
INAB reports Mar 10, 2027. The date is estimated.
INAB ETF Holders
GNG tracks 1 ETF that holds INAB.
- Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
Updated Nov 5, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About INAB
When does INAB report earnings?
In8bio Inc (INAB) is expected to report earnings on Mar 10, 2027.
Does INAB pay dividends?
In8bio Inc (INAB) does not currently pay a regular dividend.
What is INAB's market cap?
In8bio Inc (INAB) has a market capitalization of $8.86M with a current stock price of $0.82.
INAB pages: Overview, Earnings, Forecast, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.